共 388 条
[1]
Ali S(2002)Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Cancer 2 101-112
[2]
Coombes RC(2005)ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 341-354
[3]
Hynes NE(2002)Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients Br J Cancer 86 540-545
[4]
Lane HA(2003)Akt kinases in breast cancer and the results of adjuvant therapy Breast Cancer Res 5 R37-44
[5]
Perez-Tenorio G(2006)The association between Akt activation and resistance to hormone therapy in metastatic breast cancer Eur J Cancer 42 629-635
[6]
Stal O(2010)Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer J Clin Invest 120 2406-2413
[7]
Stal O(2008)ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2 Endocr Relat Cancer 15 985-1002
[8]
Perez-Tenorio G(2001)Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance J Biol Chem 276 9817-9824
[9]
Akerberg L(2008)AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer Mol Cell Biol 28 7487-7503
[10]
Olsson B(1998)Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability J Biol Chem 273 14424-14429